Private Label Retinol Alternative Eye Serum, Low MOQ

What are the regulatory requirements for launching a private label retinol alternative eye serum in different markets?

By Blake Mereby · Last reviewed November 1, 2026

Regulatory requirements for private label retinol alternative eye serums differ significantly across the US, EU, China, and other major markets, and compliance depends on your active ingredient choice, the claims you make, and where you sell. Understanding these pathways early in product development prevents costly reformulations or delayed launches. The core question is: Is your product a cosmetic or a drug? In most markets, this hinges on the claims you make rather than the ingredients alone. A retinol alternative eye serum marketed as "moisturizing" or "antioxidant" is cosmetic; one claiming to "reduce wrinkles" or "treat photoaging" may be classified as a drug and face higher regulatory barriers.

In the United States, the FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act (FDCA). If your serum makes only cosmetic claims ("hydrating," "energizing," "smoothing the appearance of fine lines"), it's classified as a cosmetic and must comply with 21 CFR 700 series rules: ingredients must be INCI-compliant, the product must be manufactured under current good manufacturing practices (cGMP), a Cosmetic Facility List (CFR 607) entry is required, and a Product Establishment Registration is required. No pre-market approval is needed. However, if you claim the product "reduces wrinkles," "treats fine lines," or "improves skin elasticity" as a therapeutic or anti-aging benefit, the product is classified as an OTC drug and must comply with 21 CFR 333 (Topical Antimicrobial and Antifungal OTC Skincare Products and Other Topical OTC Products). OTC drug classification requires: (1) the active ingredient must be on the OTC monograph (bakuchiol and retinyl esters are NOT on the OTC monograph—only salicylic acid, glycolic acid, and a few others are approved); (2) stability testing and clinical substantiation of claims (typically 4-week minimum clinical trials with standardized measurement methods like photography or profilometry); (3) specific labeling (warnings, directions, ingredient declaration under OTC rules). If your retinol alternative isn't on the monograph and you can't fund clinical trials, stick to cosmetic claims. Many brands navigate this by marketing retinol alternatives as "skin-conditioning" or "antioxidant," not anti-wrinkle, and avoiding therapeutic language. When you work with a manufacturer through the AJ Cosmo Labs app, explicitly discuss your claim strategy and ask the chemist to map your formula against FDA classification guidance.

In the European Union, the key regulation is EU Cosmetics Regulation 1223/2009, which classifies products based on ingredient safety and intended use, not claims alone. Retinyl esters and bakuchiol are permitted cosmetic ingredients in the EU. However, the EU restricts certain claims: making anti-wrinkle, anti-aging, or therapeutic claims on a retinoid-adjacent product can trigger reclassification as a medicinal product under Directive 2001/83/EC, which requires marketing authorization, clinical trials, and a Qualified Person's assessment—a pathway that's expensive and rare for cosmetics. Most European brands selling retinol alternative serums use language like "revitalizing," "firming the appearance," or "supporting skin's natural renewal" rather than claiming wrinkle reduction. Additionally, all cosmetic products sold in the EU must be registered in the CPNP (Cosmetic Products Notification Portal) before or within 30 days of first sale; this requires the product's name, ingredients (INCI), manufacturer, and country of origin. Stability testing must be conducted per ISO 11996 or equivalent, and a safety dossier (ISO 29106 or equivalent) must be compiled by a Cosmetic Safety Assessor (usually a toxicologist on staff at the manufacturer or contracted independently). The safety dossier must include stability data, microbial limits testing, and a risk assessment of all ingredients. This process typically takes 4–6 weeks and costs €800–€2,000 depending on formula complexity. Unlike the US, there's no new active ingredient monograph pathway; cosmetic ingredients are generally assumed safe if they're on the European Cosmetic Ingredient Database and have been in use historically.

In China (NMPA, formerly CFDA), the regulatory pathway has shifted. As of 2020, "ordinary" cosmetics (those not making drug-like claims and not containing prohibited ingredients) are classified as cosmetics and require less stringent approval than medicinal products. Retinyl esters and bakuchiol are generally permitted, but claims are tightly controlled. Marketing a product as an anti-wrinkle cosmetic or claiming medicinal benefits triggers classification as a "functional cosmetic" or "quasi-drug," which requires clinical trials and more extensive dossier work. Most brands in China market retinol alternatives as whitening, hydrating, or anti-oxidant products rather than anti-aging, to avoid the drug classification. All cosmetics sold in China must be registered with NMPA (imported cosmetics) or notified (domestic cosmetics), and a Cosmetic Safety Assessor (equivalent to EU rules) must compile a dossier. Stability testing per Chinese guidelines (BJGB-ZY-03 or equivalent) is required and typically takes 8–12 weeks (longer than EU protocols in some cases). Microbial and chemical stability testing costs ¥10,000–¥30,000 (approximately $1,400–$4,200). Lead times for NMPA registration are typically 8–12 weeks for imported cosmetics and 5–7 weeks for domestic notification.

In other markets: Canada (Health Canada) classifies retinol alternatives as natural and non-prescription drugs if they make drug claims; cosmetic claims only require ingredient compliance. UK (post-Brexit) now follows its own framework aligned with EU 1223/2009 but with separate registration requirements; the process mirrors the EU but takes additional time. Australia (TGA) permits retinyl esters and bakuchiol as cosmetic ingredients but restricts wrinkle-reduction claims and requires local distribution notification. Japan (MHLW) is relatively permissive on retinol alternatives marketed as cosmetics but has strict standards on stability testing and labeling. ASEAN countries (Singapore, Thailand, Malaysia, Indonesia) each have separate requirements; Singapore is the strictest and most aligned with Western standards.

Core compliance steps applicable to all markets: (1) Finalize your active ingredient and formula with your manufacturer; (2) Request that the manufacturer conduct or subcontract stability testing (12-week accelerated minimum, preferably with long-term data as well); (3) Have a toxicologist or Cosmetic Safety Assessor compile a safety dossier; (4) Draft your label with claims, ingredients, and warnings; (5) Map your claims against each target market's regulations and modify language if needed (e.g., "supports hydration" instead of "reduces wrinkles" if you're in the EU); (6) Submit registration/notification documents to each market's regulatory body if required; (7) Obtain written confirmation of compliance or registration number before launch. The cost of this full compliance pathway ranges from $3,000 (US cosmetic only, minimal testing) to $15,000+ (multiple markets, multiple stability protocols, clinical substantiation of claims). A manufacturer that includes regulatory support in their quote often saves you money and headaches compared to outsourcing each piece separately.

A critical common mistake is launching with one set of claims globally and then discovering they're non-compliant in certain markets. "Anti-wrinkle" language that's fine in the US (if supported by OTC trials or marketed as non-drug cosmetic language) is problematic in the EU and China. Plan your claim strategy by market from day one. When you post your brief on the AJ Cosmo Labs app, specify your launch markets and initial claim category (cosmetic only, or OTC drug if US), and ask the approved manufacturers which markets they have regulatory expertise in and what support they provide. A manufacturer with in-house or contracted regulatory specialists will save you months of uncertainty.

Ingredients in this answer: Retinol · Salicylic Acid · Bakuchiol · Glycolic Acid

Read the full guide on Private Label Retinol Alternative Eye Serum, Low MOQ →

More about Private Label Retinol Alternative Eye Serum, Low MOQ

Tell us about your product

Tell us what you're selling and where. You can hire a vetted cosmetic chemist on AJ Cosmo Labs to review your formula and labeling. Starting is free.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app